Barbara Kosacz, COO & General Counsel at Kronos Bio, Inc. (KRON), sold 10,676 shares at $1.18 ($13K) on 2024-01-04, disclosed to the SEC on 2024-01-05.
Open-market sale of $13k KRON by COO & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.